Agile Therapeutics | AGRX - Bénéfice Avant Impôts



Bénéfice Avant Impôts Changement Date
Adma Biologics USD 61.59M 14.07M 2025-12
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Bayer EUR -1.16B 735M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cassava Sciences USD -10.81M 33.41M 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
J&J USD 4.97B 2.53B 2025-12
Merck USD 6.74B 22M 2025-09
Pacira USD 9.52M 11.45M 2025-09
Pfizer USD 3.33B 290M 2025-09
TherapeuticsMD USD -1.05M 241K 2024-06